ZTSZoetis
What is the market doing?
No clear lean: rangebound and moderately shorted.
Rangebound, no clear trend. Price is −25% vs its 200-day average.
Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Down 11% since the previous count, up from 3.8% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ZTS is trading
Zoetis is −49% over the past year while the S&P 500 is +18%: 67 points behind the market. Through the fall, its own insiders bought $886K more stock than they sold.
1-year return · S&P 500 +18%
- vs 200-day average
- −25%
vs 200-day average · a clear downtrend
- RSI (14)
- 64
RSI (14) · neutral
- Below its 52-week high
- 49%
Below its 52-week high
Details›
- Last close2026-10-09
- $74.80
- 1 monthS&P 500 +2.7%
- +2.6%
- 1 yearS&P 500 +18%
- −49%
- 5 yearsS&P 500 +88%
- −62%
- vs 50-day average$73.99
- +1.1%
- 52-week high
- $145.76
- 52-week low
- $69.11
- Annualised volatility
- 32%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $886K
| Year | Return |
|---|---|
| 2026 (year to date) | −40% |
| 2025 | −22% |
| 2024 | −17% |
| 2023 | +36% |
| 2022 | −40% |
| 2021 | +48% |
| 2020 | +26% |
| 2019 | +56% |
| 2018 | +19% |
| 2017 | +36% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +0.07% |
| Feb | 10 | 6 of 10 | +1.8% |
| Mar | 10 | 4 of 10 | −2.9% |
| Apr | 10 | 6 of 10 | +1.4% |
| May | 10 | 6 of 10 | −0.86% |
| Jun | 10 | 8 of 10 | +2.0% |
| Jul | 11 | 9 of 11 | +3.8% |
| Aug | 11 | 9 of 11 | +1.7% |
| Sep | 11 | 5 of 11 | −2.0% |
| Oct | 11 | 5 of 11 | −0.84% |
| Nov | 10 | 7 of 10 | +2.3% |
| Dec | 10 | 5 of 10 | +1.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
The closest names by size in the same industry